Company Profile
Updated: 21-SEP-09Delcath Systems Inc.
Public Company, Headquarters Location
600 5th Ave., 23rd Fl., New York, NY 10020-2302, United States
(212)489-2100, (212)489-2102 fax, http://www.delcath.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Commercial physical and bio research traeting liver cancer, and malignant melanoma
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board.
PR Newswire; 12/22/2009; 978 words; ...in New York. About Delcath Systems, Inc. Delcath Systems Inc. is a medical device company specializing...a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing...
DELCATH SYSTEMS REPORTS ACQUISITION BY DIRECTOR CONTAG (New York)
US Fed News Service, Including US State News; 12/20/2009; 294 words; WASHINGTON, Dec. 20 -- Delcath Systems Inc. (DCTH), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
DELCATH SYSTEMS REPORTS ACQUISITION BY DIRECTOR STOLL (New York)
US Fed News Service, Including US State News; 12/19/2009; 293 words; WASHINGTON, Dec. 19 -- Delcath Systems Inc. (DCTH), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
DELCATH SYSTEMS REPORTS ACQUISITION BY DIRECTOR TANEY (New York)
US Fed News Service, Including US State News; 12/19/2009; 293 words; WASHINGTON, Dec. 19 -- Delcath Systems Inc. (DCTH), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
DELCATH SYSTEMS REPORTS ACQUISITION BY DIRECTOR KOPLEWICZ (New York)
US Fed News Service, Including US State News; 12/19/2009; 295 words; WASHINGTON, Dec. 19 -- Delcath Systems Inc. (DCTH), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
Recent News Articles
- Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin Cancer Centers.
PR Newswire - November 24, 2009 - OTC Stock Review Stocks in Motion for Thursday, November 19, 2009 are Cyplasin Biomedical Ltd., Salix Pharmaceuticals, Ltd., Affymax Inc., and Delcath Systems, Inc.
M2 Presswire - November 19, 2009 - Delcath Systems, Inc. Prices $30.6 Million Stock Offering.
PR Newswire - November 13, 2009 - Delcath Systems, Inc. Announces Public Offering of Common Stock.
Biotech Week - November 11, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning